Latest News in the pharma Industry

Market News

Wuxi Vaccines' Ireland site still on course for 2022 despite COVID challenges

Wuxi Vaccines' Ireland site still on course for 2022 despite COVID challenges

16 Mar 2021

Despite COVID-related challenges and supply chain issues, the CDMO's $240 million new facility is on target to open next year

Read more 
PCI Pharma Services expands Berlin cold chain clinical supply storage capabilities

PCI Pharma Services expands Berlin cold chain clinical supply storage capabilities

16 Mar 2021

The move ensures the service provider has the capacity to meet the needs of an evolving clinical market

Read more 
Growing drug delivery CDMO Kindeva expands UK operations

Growing drug delivery CDMO Kindeva expands UK operations

16 Mar 2021

US-headquartered company Kindeva seals deal for an R&D facility at Loughborough’s life sciences hub

Read more 
Growth opportunities abound for auto-injectors amid patient-centric healthcare transition, experts tell CPhI webinar

Growth opportunities abound for auto-injectors amid patient-centric healthcare transition, experts tell CPhI webinar

12 Mar 2021

Tremendous growth opportunities exist for auto-injectors as their value is increasingly being recognised across several therapy areas, experts have told a recent CPhI webinar, sponsored by Stevanato Group.

Read more 
ANI Pharmaceuticals expands CDMO business through Novitium acquisition

ANI Pharmaceuticals expands CDMO business through Novitium acquisition

10 Mar 2021

The purchase will allow the company to add nine new customers to its growing CDMO business and 27 manufacturing suites

Read more 
Inhalation specialist Vectura invests to expand manufacturing capabilities

Inhalation specialist Vectura invests to expand manufacturing capabilities

9 Mar 2021

The enhancements will include installing the lever-operated multi-dose inhaler device used in Hikma’s generic Advair product, which the FDA recently approved

Read more 
CPhI post-pandemic report forecasts explosion of contract services growth

CPhI post-pandemic report forecasts explosion of contract services growth

9 Mar 2021

During the next 12 months, demand for early-stage contract projects could quickly exceed supply

Read more 
Lonza to develop and manufacture Ixogen's oncolytic virus

Lonza to develop and manufacture Ixogen's oncolytic virus

8 Mar 2021

PsiVac has generated compelling efficacy data in killing a broad range of tumour cells, including head and neck, bladder, liver, pancreatic and ovarian

Read more 
Vetter opens Chinese office to support promising injectable pipeline

Vetter opens Chinese office to support promising injectable pipeline

8 Mar 2021

The strategic move will enable the injectables CDMO to support domestic companies that plan on bringing their molecules to the global market

Read more 
Merck agrees to support Johnson & Johnson in vaccine manufacturing deal

Merck agrees to support Johnson & Johnson in vaccine manufacturing deal

3 Mar 2021

Funding from BARDA helps the company to adapt and make available a number of existing manufacturing facilities for the production of SARS-CoV-2 vaccines and medicines

Read more 
WuXi AppTec completes $135 million acquisition of Oxgene

WuXi AppTec completes $135 million acquisition of Oxgene

2 Mar 2021

The addition further strengthens WuXi's cell and gene therapy service offerings for global customers and will be Wuxi ATU's first facility in Europe

Read more 
Pharmaron pays $118.7 million for AbbVie UK biomanufacturing site

Pharmaron pays $118.7 million for AbbVie UK biomanufacturing site

1 Mar 2021

This transaction complements Pharmaron’s recent acquisition of Absorption Systems in the US for building an integrated cell and gene therapy services platform

Read more